MedPath

Tranquil Moments II-CBT vs. Yoga for Worry

Not Applicable
Completed
Conditions
Anxiety
Interventions
Behavioral: Cognitive-behavioral therapy
Behavioral: Yoga
Registration Number
NCT02968238
Lead Sponsor
Wake Forest University Health Sciences
Brief Summary

Anxiety disorders are the most prevalent psychiatric disorders. Among older adults, anxiety is more common that depression, yet research on the nature and treatment of anxiety has lagged far behind that of depression. The investigators' work has demonstrated that CBT is superior to enhanced usual care as well as supportive therapy in improving worry, depressive symptoms, and sleep, and these improvements are maintained for up to 1 year upon completing treatment. Research demonstrates that yoga reduces anxiety symptoms and the investigators' own work demonstrates that yoga improves sleep. However, no one has conducted a comparative effectiveness trial of CBT and yoga for treating worry in older adults. In fact, there are very few comparative effectiveness trials for treating late-life anxiety. Thus, clinicians are unable to provide an informed recommendation of one treatment over the other. The investigators propose a two-stage randomized preference trial comparing 1) cognitive-behavioral therapy with 2) yoga for the treatment of worry in a sample of older adults. Participants will be randomized to either the preference group (participants choose the treatment) or to the random group (participants are randomized to 1 of the 2 treatments). This study design allows for the calculation of traditional treatment effects (differences in outcomes between participants randomized to either CBT or yoga), selection effects (differences in outcomes between participants who choose CBT and those who choose yoga), and preference effects (differences in outcomes between participants who choose their treatment and those who are randomized to treatment).

Detailed Description

The primary aim of this study is to compare the effects of CBT and yoga on worry in older adults (as assessed by the PSWQ-A measured at post-intervention, Week 11). Secondary aims are to compare the effects of these treatments on anxiety and sleep (as assessed by the PROMIS anxiety scale and the ISI, respectively, measured at post-intervention, Week 11). Exploratory aims are to determine participant preference for CBT vs. yoga; examine participant preference effects on worry, anxiety, sleep, adherence to treatment, and attrition rates; and examine selection effects on worry, anxiety, sleep, adherence to treatment, and attrition rates. All analyses will be repeated for measures assessed at Week 37.

The treatment effect for the primary aim will be estimated by comparing mean PSWQ-A scores between CBT and yoga groups in the random group (N=250, 125 per group) using constrained mixed-model repeated measures analysis of covariance with an unstructured covariance matrix to account for the fact that the multiple measurements (at baseline-Week 0, mid-intervention-Week 6, post-intervention-Week 11) from participants are not independent. The model will contain terms for baseline psychotropic medication use, gender and race (both related to depression), and intervention effects that are specific to each follow-up time. Because this arm of the trial has been randomized, we will constrain the pre-randomization intervention-specific outcome means to be the same. A contrast will be used to test the primary hypothesis at the post-intervention (Week 11) time point using a two-sided 0.05 significance level. In the primary analysis, all randomized participants will be included in their original study group for analysis regardless of the final mode of intervention or the extent of compliance with the study protocol; that is, the primary analysis will follow an "intent to treat" philosophy.

As part of the secondary aims, the estimation of selection and preference effects will be performed with mixed models based on the complete sample using data collected in both preference and randomized arms of the trial. Therefore, these analyses will be based on a sample size of 500 individuals. The adjusted means and variance-covariance matrix needed to compute these effects and their standard error will be estimated from the fitted model. The standard error associated with the preference and selection effects will be derived using the delta-method and/or a bootstrapping approach, as needed.

Consistency of intervention effects will be explored within the following baseline subgroups: 1) depressive symptoms from PROMIS measure (none or mild vs. moderate or severe), 2) use of psychotropic meds (any vs none), 3) age (60-79 vs 80+), 4) gender (female/male), and 5) race (White vs. other races).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
500
Inclusion Criteria
  • Age 60 years and older
  • Moderate to severe levels of worry
Read More
Exclusion Criteria
  • Currently receiving psychotherapy
  • Currently practicing yoga
  • Active alcohol/substance abuse
  • Dementia
  • Current psychotic symptoms
  • Active suicidal ideation with plan and intent
  • Hearing loss that would prevent a person from participating in telephone/class sessions
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
CBT preference armCognitive-behavioral therapyCBT preference arm consists of participants who are randomized to the preference condition and choose to receive cognitive-behavioral therapy (CBT). CBT consists of 10 weeks of weekly treatment.
Yoga preference armYogaYoga preference arm consists of participants who are randomized to the preference condition and choose to receive yoga. Yoga consists of 10 weeks of bi-weekly treatment (total = 20 treatments).
CBT randomized armCognitive-behavioral therapyCBT randomized arm consists of participants who are randomized to the random condition and are randomized to receive cognitive-behavioral therapy (CBT). CBT consists of 10 weeks of weekly treatment.
Yoga randomized armYogaYoga randomized arm consists of participants who are randomized to the random condition and are randomized to receive yoga. Yoga consists of 10 weeks of bi-weekly treatment (total = 20 treatments).
Primary Outcome Measures
NameTimeMethod
Penn State Worry Questionnaire-AbbreviatedWeek 11

worry symptoms

Secondary Outcome Measures
NameTimeMethod
PROMIS AnxietyWeek 11, Week 37

anxiety symptoms

Insomnia Sleep IndexWeek 11, Week 37

sleep problems

Penn State Worry Questionnaire-AbbreviatedWeek 37

worry symptoms

PROMIS 29Week 11, Week 37

29-item self-report measure with 4 items each for the following: physical function, anxiety, depression, fatigue, sleep, social function, pain interference; 1 item for average pain intensity

PROMIS DepressionWeek 11, Week 37

depressive symptoms

PROMIS Physical Function with Mobility AidWeek 11, Week 37

Self-report measure of current capability for physical activities

GAD-7Week 11, Week 37

Self-report symptoms of Generalized Anxiety Disorder

Cornell Medical Services IndexWeek 11, Week 37

measure of medical care utilization

Client Satisfaction QuestionnaireWeek 11

self-report measure of satisfaction with treatment

Working Alliance Inventory, Client and TherapistWeek 11, Week 37

assesses therapist-patient working alliance; measures are completed by the participant and the therapist

Adherence to the intervention as assessed by the number of sessions attendedWeek 11

adherence to treatment

Attrition from the intervention as assessed by the number of participants who do not complete study assessments at Week 11 and Week 37Week 11, Week 37

attrition from study

FallsWeek 11, Week 37

self-report incidence of falls

FES-IWeek 11, Week 37

falls self-efficacy

Trial Locations

Locations (1)

Wake Forest University Health Sciences

🇺🇸

Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath